Zhou, Y., Zhang, G., Ma, S., Shi, Q., Wan, A., Fan, L., Tang, P., Chen, L., Wang, S., Jiang, J., Zhang, Y., Qi, X., Cheng, Q., Zhou, W., Wei, Y., Chen, M., Wang, M., Wang, S., Xu, L., Xu, G. (2025). Multicenter real-world study of trastuzumab combined with pirotinib or pertuzumab as a neoadjuvant therapy for stage II-III HER-2 positive breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12609